Basic Information
Basic information for AC022034.3-209-53aa
Peptide Name AC022034.3-209-53aa
Genome Position chr8:53394810-53394968[-]
Species Human
Peptide Sequence MWTSHPHQPLRHVREARTGHPDPTVLVDETAEGISTYQQNPEKCSLLLQAAAF
Peptide Length 53
Unique No (AC022034.3-219-53aa,AC022034.3-212-53aa,AC022034.3-202-53aa,AC022034.3-222-53aa,AC022034.3-206-53aa,AC022034.3-204-53aa,AC022034.3-217-53aa,AC022034.3-210-53aa,AC022034.3-211-53aa,AC022034.3-214-53aa,AC022034.3-221-53aa,AC022034.3-203-53aa,AC022034.3-205-53aa,AC022034.3-213-53aa,AC022034.3-207-53aa,AC022034.3-201-53aa,AC022034.3-215-53aa,AC022034.3-218-53aa,AC022034.3-220-53aa,AC022034.3-216-53aa,AC022034.3-208-53aa)
Grand Average of Hydropathicity -0.6283
Relative Molecular Mass 6902.62
Experimental Evidences no
lncRNA ID/Name ENSG00000253369;AC022034.3
Transcript ID/Name ENST00000663011;AC022034.3-209
Transcript Length 1505
Coding Ability 0.5442
DNA Sequence Corresponding to Peptide ATGTGGACAAGCCATCCCCACCAGCCCCTGAGACATGTGAGAGAGGCCAGAACAGGCCATCCGGACCCCACTGTGCTGGTGGATGAGACAGCAGAAGGAATATCAACCTACCAACAGAATCCTGAGAAATGCTCACTCTTACTTCAAGCTGCTGCATTT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :